Awards 2018-04-28T00:56:04+00:00

Vay Liang & Frisca Go Award for Lifetime Achievement


Dr. Chris Forsmark was born and raised in Colorado, growing up in the mountains near Granby before his family moved to Denver. His mother, a schoolteacher, and his father, a bookkeeper, were both exceedingly well read and instilled an a ppreciation of hard work and self-improvement. He developed an interest in medicine while a high school student and g raduated from the University of Colorado, Boulder, with a degree in chemical engineering, and then attended medical sc hool at Johns Hopkins. During training at Hopkins, he developed an interest in gastrointestinal and liver diseases due to the impressive number of outstanding faculty and trainees.

He received the Warfield Longcope prize (best student in int ernal medicine), along with election to Phi Beta Kappa and Alpha Omega Alpha at graduation. He moved to the Univers ity of California, San Francisco for internal medicine training, chief residency, and GI fellowship. It was here that he beca me specifically interested in pancreatic diseases, due to mentorship and inspiration from Jim Grendell, John Cello, and Roger Liddle. It was also here that he developed life-long connections with others interested in the pancreas and fibrosi s including Mel Wilcox, Scott Friedman, and Brent Neuschwander-Tetri.

Dr. Forsmark is at heart a clinician, involved in both the medical management and endoscopic management of many patients with acute and chronic pancreatitis and with pancreatic malignancies. In conjunction with Phil Toskes, a rather unique training program combining advanced endoscopy and medical pancreatolology was created at UF, which now has numerous graduates. Much of his research has focused on issues that combine the endoscopic and medical approaches to these patients, and in particular methods of early diagnosis of chronic pancreatitis. He is the author of more than 90 peer-reviewed publications, numerous book chapters, and multiple reviews and editorials. Most recently, he and his colleagues at UF participate in the NIDDK/NCI UO-1 consortium to study chronic pancreatitis, diabetes, and pancreatic cancer. This 5-10 year project will attempt to delineate the intricate and tri-directional relationships between these diseases, with a goal of more accurate diagnosis, more effective therapy, and earlier detection. Dr Forsmark and Dr Steven Pandol chair this UO-1 consortium.

Dr. Forsmark wishes to express his gratitude to the APA for the tremendous honor of the Go Lifetime Achievement Award, and to Bill and Frisca Go for their generosity. He feels there are so many people who are equally deserving of recognition within the APA. He is especially thankful for the advice and guidance provided by leaders in the APA, including Bill Go, Ashok Saluja, Howard Reber, Ed Bradley, Roger Liddle, Phil Toskes, Raul Urrutia, and so many others. He would also like to acknowledge and thank his wife Rusty, who for 36 years has provided support, counsel and love, and his 2 (outstanding) daughters Kate and Britta.

Distinguished Service Award


Dr. Srivastava is Senior Scientific Officer and Chief of the Cancer Biomarkers Research Group in the Division of Cancer Prevention, National Cancer Institute. He joined the National Cancer Institute in 1988. Since 1990, he has served as program director in the Division of Cancer Prevention and focused his responsibility in developing molecular signatures of cancer cells for cancer detection research programs with primary emphasis on cancer screening, early detection, risk assessment and informatics.

Dr. Srivastava is an internationally recognized leader in cancer biomarker research. He is best known for his seminal contributions to improving systems approach to biomarker discovery, development and validation. In 2000, Dr. Srivastava developed and implemented a novel approach to collaborative clinical research on cancer biomarkers through the establishment of the Early Detection Research Network (EDRN; ), a flagship program at the National Cancer Institute, National Institutes of Health. Under his leadership the network has begun translating biomarkers into clinical tests for early detection and diagnosis, risk assessment, and prognosis. He has spearheaded the role of chemical sciences in oncology by establishing the NCI’s Alliance of Glycobiologists ( to study the structure-function relationship of glycans and biomarkers in cancer detection and diagnosis. He has played a key role in conceptualizing and implementing informatics infrastructure for the EDRN in collaboration with NASA (Jet Propulsion Laboratory), a model collaboration being followed elsewhere in NIH. For his creativity, he received a JPL Group Achievement Award in 2011.

Dr. Srivastava is best known for his work on developing medical guidelines on the diagnosis of Hereditary Non-polyposis Colorectal Cancer (HNPCC). He played a pivotal role in the development of the Bethesda Guidelines for diagnosing HNPCC, which is in clinical practice world-wide. He has received several honors and awards and is a member of a number of scientific committees world-wide. In 1995, he was elected to the American Joint Committee on Cancer (AJCC) which is responsible for developing staging criteria for cancers for worldwide use and currently serves on the AJCC Executive Committee. He has been a visiting Professor at several medical and academic institutions, and has delivered several inaugural and keynote addresses.

He is the founding Editor-in Chief of the journal Cancer Biomarkers, and was the editor of Disease Markers (2002-2013) published by the IOS press and serves as Associate Editors and reviewers for several internally know journals. He has published more than 200 research papers, review articles and commentaries in peer reviewed journals. He has edited several monographs and edited five books.

In 2016, he received a Cancer Prevention Distinguished Alumni Award for his accomplishments and mentoring of fellows. He was featured in Wired magazine in August 2003 for his leadership in cancer diagnostics. He has been planning and managing comprehensive extramural scientific programs for more than 26 years. This year, he was also invited to brief the US Congress on progress made on biomarkers for cancer early detection. He has successfully managed several mission-critical goals of the National Cancer Institute at various fronts including: conceptual, infrastructure, dependency linkage, and coordination among various federal, academic and private sector constituents. For these activities, he has received numerous NIH Director Awards and NIH Merit Awards.

Dr. Srivastava received his PhD. Degree in biological science from Banaras Hindu University in 1977. Subsequently, he received his M.S. degree in Computer Science from the Virginia Commonwealth University in 1987 and a MPH degree from the Johns Hopkins University in 1997. He did postdoctoral work at the University of Osaka, Japan; the University of California at San Francisco; and the University of Arizona, Tucson.

Hirshberg Award

Each year, the Hirshberg Foundation gives an award to the best abstracts in pancreatic cancer presented at the Annual Meeting. In 2016, the awards went to:


Each year, the Hirshberg Foundation gives an award to the best abstracts in pancreatic cancer presented at the Annual Meeting. In 2016, the awards went to:


Il-6 And Pd-l1 Antibody Blockade Combination Therapy Limits Tumor Progression In Murine Models Of Pancreatic Cancer

NPF Award

Each year, the National Pancreas Foundation gives an award to the best basic science and clinical abstracts in pancreatitis. In 2016, the awards went to:


Downregulation of Atg4b Stimulates Autophagy and Ameliorates Alcohol-induced Pancreatic Injury


Endoscopic or Surgical Step-up Approach for Necrotizing Pancreatitis, A Multi-center Randomized Controlled Trial

Presidential Award for Best Basic Science Abstract

With the large number of basic science abstracts submitted this year, we wanted to also recognize the exceptional work done in this category. At the 2016 meeting, the award went to:


Bile Acids(BA) in Human Pancreatic Necrosis(PN) Worsen Acute Pancreatitis(AP) via a Non-micellar Interaction With Fatty Acids(FA).